Location History:
- Kanagawa, JP (2020)
- Ashigarakami-gun, JP (2023)
Company Filing History:
Years Active: 2020-2025
Title: Shino Ohira: Innovator in Pharmaceutical Technology
Introduction
Shino Ohira is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of methods and devices that enhance the efficiency of drug discovery and molecular structure analysis. With a total of 3 patents to her name, her work is recognized for its innovative approach to solving complex problems in chemistry and pharmacology.
Latest Patents
Shino Ohira's latest patents include a feature quantity calculating method, a feature quantity calculating program, and a feature quantity calculating device. These inventions enable the accurate calculation of feature quantities that reflect the chemical properties of target structures. Additionally, she has developed a screening method, a screening program, and a screening device that facilitate the efficient screening of pharmaceutical candidate compounds using these feature quantities. Furthermore, her compound creating method, program, and device allow for the efficient creation of three-dimensional structures of pharmaceutical candidate compounds.
Career Highlights
Shino Ohira is currently employed at Fujifilm Corporation, where she continues to innovate in the field of pharmaceutical technology. Her work focuses on enhancing the accuracy and efficiency of molecular structure analysis and drug candidate screening. Her inventions are pivotal in advancing the capabilities of researchers in the pharmaceutical industry.
Collaborations
Shino collaborates with notable colleagues, including Kyosuke Tsumura and Jun Nakabayashi. These partnerships contribute to the development of cutting-edge technologies in the pharmaceutical sector.
Conclusion
Shino Ohira's contributions to pharmaceutical technology through her innovative patents and collaborative efforts position her as a key figure in the field. Her work not only enhances the efficiency of drug discovery but also paves the way for future advancements in molecular analysis.